PRESS RELEASE published on 03/13/2025 at 06:58, 10 months 25 days ago DocMorris achieves 2024 targets, expects Rx growth of around 50 per cent in the first quarter of 2025 and plans capital increase DocMorris achieves 2024 targets, expects Rx growth of around 50% in Q1 2025 and plans CHF 200 million capital increase. Revenue targets met, positive results in Germany & Europe Revenue Growth Capital Increase 2024 Targets DocMorris Rx Growth
BRIEF published on 02/27/2025 at 12:41, 11 months 8 days ago ECJ Ruling Impacts DocMorris Advertising Strategy DocMorris AG ECJ Ruling Prescription Medicine Discounts German Court Case Advertising Regulations
BRIEF published on 02/27/2025 at 12:41, 11 months 8 days ago La décision de la CJUE impacte la stratégie publicitaire de DocMorris DocMorris AG Arrêt De La CJCE Rabais Sur Les Médicaments Sur Ordonnance Affaire Judiciaire Allemande Réglementation Sur La Publicité
PRESS RELEASE published on 02/27/2025 at 12:36, 11 months 8 days ago DocMorris AG: ECJ Ruling on advertising for prescription medicines DocMorris AG: ECJ ruling permits Rx discount promotions with vouchers for beauty and personal care products. Company to focus on digitalization and e-prescriptions growth in Germany Digitalization DocMorris AG ECJ Ruling Prescription Medicines Discount Promotions
BRIEF published on 01/21/2025 at 07:03, 1 year ago DocMorris Reports 6.7% Growth in 2024 with Strong Rx Revenue Surge 2024 Financial Results DocMorris Growth Rx Revenue Increase TeleClinic Performance German Market Trends
BRIEF published on 01/21/2025 at 07:03, 1 year ago DocMorris annonce une croissance de 6,7 % en 2024 avec une forte augmentation des revenus des médicaments sur ordonnance Résultats Financiers 2024 Croissance De DocMorris Augmentation Des Revenus Des Médicaments Sur Ordonnance Performances De La TéléClinique Tendances Du Marché Allemand
PRESS RELEASE published on 01/21/2025 at 06:58, 1 year ago DocMorris grows 6.7 per cent in 2024 and accelerates Rx growth in the fourth quarter DocMorris grows 6.7% in 2024 with increased Rx sales, OTC revenues and TeleClinic profits. Achieved revenue target and positive cash position. Outlook confirmed for 2024 Revenue Growth DocMorris Rx Sales TeleClinic OTC Revenues
BRIEF published on 10/15/2024 at 07:03, 1 year 3 months ago DocMorris Accelerates Prescription Medicine Growth Revenue Growth Telehealth DocMorris AG Prescription Medicine Logistics Closure
BRIEF published on 10/15/2024 at 07:03, 1 year 3 months ago DocMorris accélère la croissance des médicaments sur ordonnance Croissance Des Revenus Télésanté DocMorris AG Médicaments Sur Ordonnance Fermeture Logistique
PRESS RELEASE published on 10/15/2024 at 06:58, 1 year 3 months ago DocMorris accelerates Rx growth DocMorris accelerates Rx growth with a 12.2% revenue increase in Q3, new CTO appointed, and logistics site closure in Germany. Strong growth in e-prescriptions and customer base E-prescriptions DocMorris CTO Appointment Rx Growth Logistics Site Closure
Published on 02/07/2026 at 01:00, 23 hours 46 minutes ago Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 1 day 1 hour ago Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Published on 02/06/2026 at 22:01, 1 day 2 hours ago Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan
Published on 02/06/2026 at 15:30, 1 day 9 hours ago Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 02/06/2026 at 13:30, 1 day 11 hours ago Redwood AI Corp. (formerly Marshall Technologies Corp.) Announces Closing of IPO and Listing of Shares on the Canadian Securities Exchange
Published on 02/07/2026 at 21:00, 3 hours 46 minutes ago Alibaba Group Debuts 'Wonder on Ice,' an Immersive AI Experience at Milan’s Sforza Castle for Milano Cortina 2026
Published on 02/07/2026 at 16:35, 8 hours 11 minutes ago The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies
Published on 02/07/2026 at 16:20, 8 hours 26 minutes ago NOTICE OF SETTLEMENT APPROVAL HEARING - SHORT FORM - WAYLAND GROUP CORP., SCOTT LANGILLE, GERHARD MÜLLER, PAUL PATHAK, ERIC SILVER, MICHAEL STEIN, JOHN DOES 1-3, CANACCORD GENUITY CORP., AND RF SECURITIES CLEARING LP (FORMERLY KNOWN AS GMP SECU
Published on 02/06/2026 at 19:25, 1 day 5 hours ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/06/2026 at 17:52, 1 day 6 hours ago EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG
Published on 02/06/2026 at 18:22, 1 day 6 hours ago Déclaration du nombre d’actions et droits de vote au 31 janvier 2026
Published on 02/06/2026 at 18:22, 1 day 6 hours ago Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 1 day 8 hours ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/06/2026 at 16:01, 1 day 8 hours ago Exercice de l’option de remboursement de l'instrument subordonné FR0010093328
Published on 02/06/2026 at 07:54, 1 day 16 hours ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 janvier 2026
